{"id":"norvinisterone","rwe":[],"tags":[{"label":"norvinisterone","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"neoprogestin","offLabel":[],"synonyms":["norvinisterone","neoprogestin"],"timeline":[],"approvals":[],"brandName":"Neoprogestin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"norvinisterone","explanation":"Think of progesterone like a key that unlocks certain processes in the body. Neoprogestin is like a similar key that can fit into those locks, but instead of turning them, it blocks or changes the way they work. This can affect how the body regulates hormones and other processes.","oneSentence":"Neoprogestin works by interacting with progesterone receptors in the body.","technicalDetail":"Neoprogestin is a norvinisterone that binds to progesterone receptors, potentially modulating their activity and influencing downstream signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3390","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NORVINISTERONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:06:39.730620","biosimilars":[],"competitors":[],"genericName":"norvinisterone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7Q843V12Q0","CHEBI":"CHEBI:135270","INN_ID":"940","UMLSCUI":"C2825279","ChEMBL_ID":"CHEMBL2106828","PUBCHEM_CID":"65588"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Neoprogestin, also known as norvinisterone, is a small molecule drug in the norvinisterone class. Its exact target and mechanism of action are unknown, but it is believed to work by interacting with progesterone receptors in the body. Neoprogestin's commercial status and approved indications are currently unclear. Further research is needed to determine its efficacy and safety profile. As a result, it is not yet available on the market.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}